Skip to main content
SpringerLink
Log in

Adalimumab/golimumab/infliximab

Lack of efficacy, infusion reaction and drug eruption: 21 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Marutani Y, et al. Efficacies of first and second tumor necrosis factor inhibitors in refractory ulcerative colitis patients in real-world practice. Indian Journal of Gastroenterology 39: 565-575, No. 6, Dec 2020. Available from: URL: http://doi.org/10.1007/s12664-020-01092-1

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab/golimumab/infliximab. Reactions Weekly 1849, 21 (2021). https://doi.org/10.1007/s40278-021-93405-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-93405-8

Search

Navigation